Mark Hurwitz, MD, FACRO

Contact Dr. Hurwitz

111 South 11th Street
Bodine Cancer Center,
Suite G-301
Philadelphia, PA 19107

(215) 955-6644
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements
  2. Quality assurance guidelines for superficial hyperthermia clinical trials: II. Technical requirements for heating devices | Leitlinien zur Qualitätssicherung der lokalen Hyperthermie in klinischen Studien: II. Technische Anforderungen an Heizgeräte
  3. Oncologic applications of magnetic resonance guided focused ultrasound
  4. Using a conformal water bolus to adjust heating patterns of microwave waveguide applicators
  5. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  6. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  7. Feasibility of brachytherapy as monotherapy for high-volume, low-risk prostate cancer
  8. Optimization of chest wall hyperthermia treatment using a virtual human chest model
  9. Focused ultrasound for treatment of bone tumours
  10. Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data
  11. International consensus on use of focused ultrasound for painful bone metastases: Current status and future directions
  12. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation
  13. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: Phase III trial results
  14. High dose rate brachytherapy boost for prostate cancer: A systematic review
  15. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  16. Components of a hyperthermia clinic: Recommendations for staffing, equipment, and treatment monitoring
  17. Hyperthermia, radiation and chemotherapy: The role of heat in multidisciplinary cancer care
  18. The quality frontier
  19. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
  20. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma